Guidance for market authorization requirements...
Dataset description:
Modified requirements for COVID-19 drugs allow for the filing of rolling submissions (section C.08.002(2.3) of Canada's Food and Drug Regulations). The ability to review data from early...
Source: Guidance for market authorization requirements for COVID-19 drugs: Rolling submissions and reviews
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 20, 2025 |
| Metadata last updated | October 20, 2025 |
| Created | October 20, 2025 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | 7d9e34d7-6e04-4a1e-9c5b-852b0366886e |
| Package id | a1fa8cc9-9cd5-4410-95ab-15b5334bdecc |
| Position | 1 |
| State | active |